Vertex, Inc.

Vertex, Inc.

VERX
Vertex, Inc.US flagNASDAQ Global Market
12.79
USD
-1.06
- -
2.07BMarket Cap
Vertex, Inc.
VERX
(NASDAQ Global Market)

Recent

price

12.79

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1,297.16
2.48
2.85
2.88
3.29
3.77
4.3
4.71
4.7
Revenue per Share
-29.08
0.24
-0.57
-0.01
-0.08
-0.09
-0.34
0.05
-0.04
Basic EPS, GAAP
224.45
0.42
0.29
0.4
0.12
0.17
0.64
0.44
0.55
Free Cash Flow per Basic Share
133.45
0.22
1.11
0.02
- -
- -
- -
- -
- -
Dividend per Share
-418.97
-0.7
0.2
0.17
0.08
- -
-0.34
-0.29
-0.3
Book Value per Share
-641.72
-1.11
1.36
-0.51
-0.44
-0.3
-1.42
-1.09
-1.19
Tangible Book Value per Share
- -
130
132
148
150
152
155
159
163
Basic Weighted Avg Shares
272
322
375
426
492
572
667
748
768
Sales/Revenue/Turnover
10.96
9.91
-27.96
-0.69
-1.64
-3.06
2.29
-1.96
-2.71
Operating Margin (%)
25
25
32
45
61
74
87
101
105
Depreciation Expense
-6
31
-75
-1
-12
-13
-53
7
-6
Net Income, GAAP
- -
- -
- -
- -
- -
- -
2,862.13
4.86
27.31
Effective Tax Rate (%)
-2.24
9.66
-20.04
-0.35
-2.5
-2.29
-7.91
0.96
-0.84
Profit Margin (%)
-106
-169
111
-173
-160
-174
-1
-14
-78
Working Capital
50
1
- -
24
67
61
348
346
346
LT Debt
-112
-112
229
230
230
253
179
259
247
Total Equity
- -
- -
- -
- -
- -
- -
-101.82
-2.48
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
-28.87
2.39
-15.78
Return on Capital (%)
- -
- -
- -
-5.81
-65.42
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
4
4
4
LT Borrowings
337
337
338
LT Finance Leases
10
9
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
159
159
159
Market Capitalization
3,928
3,251
1,944

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
519
561
489
Cash, Cash Equivalents & STI
314
314
252
Accounts Receivable, Net
132
183
159
Inventories
- -
- -
- -
Total Current Liabilities
516
575
567
Payables & Accruals
99
105
104
ST Debt
4
4
4
Deferred Revenue
334
383
393

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
5.11%
44.36%
Free Cash Flow
- -
57.01%
-30.03%
Net Income, GAAP
- -
165.87%
-113.68%
Sales/Revenue/Turnover
- -
14.86%
12.25%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
157
161
170
178
667
2025
177
185
192
195
748
2026
197
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.03
0.05
-0.43
-0.34
2025
0.07
-0.01
0.03
-0.04
0.05
2026
-0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Vertex, Inc. is a technology company primarily engaged in providing tax compliance, tax automation, and related software solutions. The company offers a comprehensive suite of products and services including indirect tax software for managing sales and use tax, value-added tax (VAT), goods and services tax (GST), and other transactional taxes globally; automated tax determination software; tax data management solutions; cloud-based and on-premise tax compliance software; and integrated tax engines for enterprise resource planning (ERP) systems. Vertex’s product portfolio supports a range of industries including retail, manufacturing, financial services, and telecommunications, serving customers worldwide. The company also provides implementation, consulting, and support services to help businesses comply with evolving tax regulations. Founded in 1978 and headquartered in King of Prussia, Pennsylvania, Vertex operates internationally with offices and clients across North America, Europe, and Asia. Recently, Vertex has expanded its capabilities through strategic partnerships and new product launches aimed at enhancing its global tax compliance automation offerings. In the past 1-2 years, the company has focused on advancing its cloud-based tax solutions to better address digital tax complexities and cross-border tax compliance challenges. Vertex continues to invest in technology upgrades and integrations to support multinational corporations’ growing needs, positioning itself as a leader in the tax technology industry. These developments reflect Vertex’s commitment to innovation and broadening its market reach, underscoring its role in delivering advanced tax software solutions to help businesses navigate increasingly complex global tax landscapes. The company leverages its proprietary tax engine and extensive tax content database to deliver precise and scalable tax management solutions. Vertex is recognized for its strong customer support and technology-driven approach, targeting large enterprises and mid-market companies needing comprehensive tax automation and compliance tools. This dynamic business environment and Vertex’s expansions highlight the company’s strategic focus on maintaining leadership in the evolving tax technology sector through continuous product enhancement and global operational growth.

Company News

APIChat
  • Madrigal Pharmaceuticals Could Become The Next Vertex

  • FDA Accepts Vertex's BLA for Povetacicept in IgA Nephropathy

  • Vertex Stock Down Nearly 8% in 3 Months: Time to Buy or Stay Cautious?

  • Vertex to Present at the 46th Annual William Blair Growth Stock Conference

  • New Vertex Research Highlights Rising Revenue Risk from IT, Tax, and Finance Misalignment

  • Vertex Q1 Earnings Call Highlights

  • Vertex: Profitability Ramps Up As Company Drives Efficiency Initiatives

  • Vertex, Inc. (VERX) Q1 2026 Earnings Call Transcript

  • Compared to Estimates, Vertex (VERX) Q1 Earnings: A Look at Key Metrics

  • Vertex (VERX) Tops Q1 Earnings and Revenue Estimates

  • Vertex Announces First Quarter 2026 Financial Results

  • Vertex Pharmaceuticals Q1 Earnings Review: Pharma May Need Bolder M&A Strategy

  • Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany

  • These Analysts Revise Their Forecasts On Vertex Pharmaceuticals After Q1 Earnings

  • Vertex tops profit estimates as sales of new cystic fibrosis drug surge

  • Vertex Reports First Quarter 2026 Financial Results

  • Vertex Gears Up to Report Q1 Earnings: What Investors Can Expect

  • A Look at Vertex Inc (VERX) After 7.2% Gain -- GF Value $35.82 vs Price $12.52

  • Vertex Pharmaceuticals: Looking For Signs Of Success In Q1 Earnings

  • Is Vertex Pharmaceuticals' Empire in Trouble?